Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease

Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease

10.1152/AJPLUNG.00305.2021

Saved in:

Bibliographic Details
Main Authors:	Peng, Y, Zhao-Ni Wang, Chen, SY, Xu, AR, Fang, ZF, Sun, J, Zhou, ZQ, Hou, XT, Cen, LJ, Ma, JJ, Zhao, JC, Guan, WJ, Wang, DY, Zhong, NS
Other Authors:	OTOLARYNGOLOGY
Format:	Article
Published:	American Physiological Society 2022
Subjects:	ACE2 COPD SARS-CoV-2 club cell in vitro Angiotensin-Converting Enzyme 2 COVID-19 Epithelial Cells Humans Lung Peptidyl-Dipeptidase A Pulmonary Disease, Chronic Obstructive
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/230740
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023)

Modelling lockdown and exit strategies for COVID-19 in Singapore
by: DICKENS, BORAME SUE LEE, et al.
Published: (2021)

Longitudinal wastewater-based surveillance for SARS-CoV-2 in high-density student dormitories in Singapore
by: Ng, Wei Jie, et al.
Published: (2024)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Siti Naqiah Amrun, et al.
Published: (2020)

Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
by: Seow, Justine Jia Wen, et al.
Published: (2022)

Rapid production of clinical-grade SARS-CoV-2 specific T cells.
by: Leung, Wing, et al.
Published: (2022)

A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection
by: Gan, Esther S., et al.
Published: (2022)

Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility
by: Cheng, Hui Mei, et al.
Published: (2021)

MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti?COVID?19 Therapeutics
by: Teodori, L., et al.
Published: (2021)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Budhraja, Anshul, et al.
Published: (2022)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro
by: Zhang, Haiping, et al.
Published: (2021)

Early pathogenesis profiles across SARS-CoV-2 variants in K18-hACE2 mice revealed differential triggers of lung damages
by: Aw, Zhen Qin, et al.
Published: (2023)

Disease prevalence matters: Challenge for SARS-CoV-2 testing
by: Lau, Chin-Shern, et al.
Published: (2022)

Screening, expression, and identification of nanobody against SARS-CoV-2 spike protein
by: Su, Qianling, et al.
Published: (2023)

Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)

Memory T Cell Responses Targeting the SARS Coronavirus Persist up to 11 Years Post-Infection
by: Ng, Oi Wing, et al.
Published: (2016)

Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023)

Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023)

EVALUATION OF ADAPTIVE IMMUNITY INDUCED BY VACCINATION AND INFECTION
by: NICHOLAS KHOO KIM HUAT
Published: (2023)

Laboratory practice in the face of Covid-19
by: Lau, C.S., et al.
Published: (2021)

Dicoumarol is an effective post-exposure prophylactic for SARS-CoV-2 Omicron infection in human airway epithelium.
by: Peng, Yang, et al.
Published: (2023)

Structural basis and function of the N terminus of SARS-CoV-2 nonstructural protein 1
by: Zhao, Kaitao, et al.
Published: (2022)

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
by: Chan, Yi-Hao, et al.
Published: (2022)

Making waves: wastewater surveillance of SARS-CoV-2 in an endemic future
by: Wu, Fuqing, et al.
Published: (2022)

Environmental contamination of SARS-CoV-2 in a non-healthcare setting
by: Wong, Judith Chui Ching, et al.
Published: (2021)

Oligomerization-dependent beta-structure formation in SARS-CoV-2 envelope protein
by: Surya, Wahyu, et al.
Published: (2023)

Making waves : wastewater surveillance of SARS-CoV-2 for population-based health management
by: Thompson, Janelle R., et al.
Published: (2021)

COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection
by: Mahyuddin, Aniza P., et al.
Published: (2024)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
by: Amrun, S.N., et al.
Published: (2021)

Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
by: CS, L., et al.
Published: (2022)

Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit
by: Wu, Yanjun, et al.
Published: (2024)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
by: Ho, Tzu-Chuan, et al.
Published: (2022)

Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
by: Sampath, V, et al.
Published: (2022)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
by: Wang, R, et al.
Published: (2022)

Safety and potential efficacy of cyclooxygenase-2 inhibitors in coronavirus disease 2019
by: Ong, S.W.X., et al.
Published: (2021)

Facing a disruptive threat: how can a nuclear medicine service be prepared for the coronavirus outbreak 2020?
by: Lam, Winnie Wing-Chuen, et al.
Published: (2023)